Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: "Sinisa Savic" Clear advanced filters
  • Biologic therapies that target interleukin (IL)-1 are known to dramatically improve symptoms of a group of rare, heritable chronic inflammatory diseases. The results of a phase III trial confirm the place of canakinumab in the treatment arsenal for these disorders.

    • Sinisa Savic
    • Michael F. McDermott
    News & Views
    Nature Reviews Rheumatology
    Volume: 5, P: 529-530
  • Three monogenic diseases, with features of both autoinflammation and autoimmunity, were described for the first time in 2014. As well as providing insights into the molecular basis of several rare immunological disorders, the discoveries have implications for their diagnosis and treatment.

    • Sinisa Savic
    • Michael F. McDermott
    News & Views
    Nature Reviews Rheumatology
    Volume: 11, P: 67-68